...
首页> 外文期刊>Journal of oncology >ANXA2 Silencing Inhibits Proliferation, Invasion, and Migration in Gastric Cancer Cells
【24h】

ANXA2 Silencing Inhibits Proliferation, Invasion, and Migration in Gastric Cancer Cells

机译:ANXA2沉默抑制胃癌细胞中的增殖,侵袭和迁移

获取原文
获取原文并翻译 | 示例

摘要

Annexin A2 (ANXA2) has been well known to associate with the progress of malignant tumor. However, the biological behavior of ANXA2 in gastric cancer (GC) remains unclear. We made a hypothesis in transcriptome level from TCGA datasets. Then, we used immunohistochemical staining to quantify the expression level of ANXA2 protein in GC tissues compared with adjacent tissues. Quantitative real-time PCR and western blot were used for analyzing ANXA2 expression in human GC (SGC-7901, MKN-45, BGC-823, and AGS) cell lines. We investigated the effect of a lentivirus-mediated knock-down of ANXA2 on the proliferation, invasion and migration of gastric cancer AGS cells. Cell proliferation was examined by MTT and colony formation tests. Cell apoptosis and cycle were measured by flow cytometry. Migration and invasion were detected by transwell assay. We found that high expression of ANXA2 can increase the mobility of cancer cells from TCGA datasets. ANXA2 was upregulated in GC tissues compared with adjacent tissues. AGS cell line displayed significantly higher expression of ANXA2 among the four GC cell lines. In addition, ANXA2 silencing led to a weakened ability of proliferation, invasion, and migration in GC cells; targeting of ANXA2 may be a potential therapeutic strategy for GC patients.
机译:Annexin A2(ANXA2)已众所周知,可与恶性肿瘤的进展相关联。然而,ANXA2在胃癌(GC)中的生物学行为仍不清楚。我们在从TCGA数据集进行了转录组水平的假设。然后,我们使用免疫组织化学染色,与相邻组织相比,在GC组织中量化ANXA2蛋白的表达水平。用于分析人GC(SGC-7901,MKN-45,BGC-823和AGS)细胞系中的定量实时PCR和Western印迹。我们调查了慢病毒介导的ANXA2对胃癌AGS细胞增殖,侵袭和迁移的影响。通过MTT和菌落形成试验检查细胞增殖。通过流式细胞术测量细胞凋亡和循环。 Transwell测定检测迁移和侵袭。我们发现ANXA2的高表达可以增加来自TCGA数据集的癌细胞的迁移率。与相邻组织相比,在GC组织中上调ANXA2。 AGS细胞系在四种GC细胞系中显示出ANXA2的显着更高。此外,ANXA2沉默导致GC细胞增殖,侵袭和迁移的能力削弱; ANXA2的靶向可能是GC患者的潜在治疗策略。

著录项

  • 来源
    《Journal of oncology》 |2019年第2期|共13页
  • 作者单位

    Harbin Med Univ Canc Hosp Haping Rd Harbin 150081 Heilongjiang Peoples R China;

    Harbin Med Univ Canc Hosp Haping Rd Harbin 150081 Heilongjiang Peoples R China;

    Harbin Med Univ Canc Hosp Haping Rd Harbin 150081 Heilongjiang Peoples R China;

    Harbin Med Univ Canc Hosp Haping Rd Harbin 150081 Heilongjiang Peoples R China;

    Harbin Med Univ Canc Hosp Haping Rd Harbin 150081 Heilongjiang Peoples R China;

    Harbin Med Univ Canc Hosp Haping Rd Harbin 150081 Heilongjiang Peoples R China;

    Harbin Med Univ Canc Hosp Haping Rd Harbin 150081 Heilongjiang Peoples R China;

    Harbin Med Univ Canc Hosp Haping Rd Harbin 150081 Heilongjiang Peoples R China;

    Harbin Med Univ Canc Hosp Haping Rd Harbin 150081 Heilongjiang Peoples R China;

    Harbin Med Univ Coll Pharm Key Lab Cardiovasc Med Res Minist Educ Dept Pharmacol State Prov Key;

    Harbin Med Univ Coll Pharm Key Lab Cardiovasc Med Res Minist Educ Dept Pharmacol State Prov Key;

    Harbin Med Univ Coll Pharm Key Lab Cardiovasc Med Res Minist Educ Dept Pharmacol State Prov Key;

    Harbin Med Univ Canc Hosp Haping Rd Harbin 150081 Heilongjiang Peoples R China;

    Harbin Med Univ Canc Hosp Haping Rd Harbin 150081 Heilongjiang Peoples R China;

    Harbin Med Univ Coll Pharm Key Lab Cardiovasc Med Res Minist Educ Dept Pharmacol State Prov Key;

    Harbin Med Univ Canc Hosp Haping Rd Harbin 150081 Heilongjiang Peoples R China;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类 肿瘤学;
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号